HCM Marketplace

WEBCAST ON CD

Government scrutiny costs Bristol-Myers Squibb
Last month, pharma giant Bristol-Myers Squibb agreed to pay $515 million to settle litigation for off-label marketing, kickbacks, and pricing fraud. The government alleged that from 2000 through mid-2003, BMS paid illegal remuneration to healthcare providers and physicians to persuade them to buy BMS drugs, and maintained false, inflated prices for various oncology and generic drugs. The government also alleged that BMS promoted the sale and use of Abilify for off-label uses and misreported its lowest price for Serzone.

Learn how you can avoid the fate of BMS by minimizing government scrutiny and maintaining compliance. Find out how to predict in which areas the government will monitor pharmaceutical companies in the future. Determine whether your company’s board of directors is designed to prevent such compliance breaches.

Answers to all your questions
Listen to this 60-minute webcast, “The Bristol-Myers Squibb Settlement: Off-label, pricing fraud, and kickback lessons learned.”  Former Assistant U.S. Attorneys Christopher Hall, Esq. (currently with Saul Ewing, LLP) and Stephen McConnell, Esq. (Dechert, LLP) will discuss the ramifications of the Bristol-Myers Squibb case and how your company can learn from it. They use their experience as federal prosecutors to provide insight into government expectations in the current regulatory environment. They also evaluate why off-label marketing in combination with another violation is such an attractive target for government prosecution, and offer ideas, such as product discussion templates, that you can implement in order to maintain compliance.

At the conclusion of this Webcast, participants will be able to:

• Identify the specific challenges that faced Bristol-Myers Squibb and the context of the allegations
• Indicate the significance of the penalties passed down to Bristol-Myers Squibb and the differences between criminal (jail time) and civil (hefty fines) prosecution
• Implement methods to withstand government scrutiny
• Predict future government target areas

Agenda

• The charges brought against BMS
• Prior BMS Settlements
• The Relators
• AWP
• Anti-Kickback
• Off-label Promotion
• Government Leveraging of Charges
• The penalties
  • Payments to federal and state governments
  • Attorneys' fees
  • Another CIA
  • Increased scrutiny
• Perspectives: BMS settlement vs. comparable cases
• How to avoid compliance breaches
• Reporting AWP
• Controlling the sales process
• Dealing with whistleblowers
• Hotline best practices
• Models for internal investigations
• Question & Answer Session

Meet the Speakers
Christopher R. Hall, Esq., Mr. Hall is a partner with Saul Ewing LLP and is a former federal prosecutor. He represents corporations and individuals facing allegations of wrongful conduct. He assists clients during internal investigations, government criminal investigations, government civil enforcement actions, and related civil proceedings such as False Claims Act and securities fraud proceedings. Mr. Hall places particular emphasis on the heath care, financial service, defense, and government contract industries. He has tried more than 30 cases to verdict in federal courts.

Stephen J. McConnell, Esq. is a partner in the mass torts and product liability group with Dechert LLP in Philadelphia. He served as an Assistant United States Attorney in the Central District of California (Los Angeles), where he investigated and prosecuted criminal cases in the Major Frauds Section. Stephen has first-chair experience in both government and private practice cases, and has successfully argued significant matters before federal and state trial and appellate courts.

Who Should Attend this Webcast?

Pharmaceutical and Biotech professionals in the following fields:

• Legal Affairs
• In-house legal counsel
• Compliance
• Regulatory
• Marketing/Sales (leadership)
  

Program Materials

You will receive program slides, and other materials that you can print and distribute to all of your peers at your location. Purchase a CD of the program and listen when you can. It's also a perfect training tool for new staff or as a refresher for veteran staff.

• Webcasts

• Other Life Sciences Products